Top

Published in:

01-06-2009 | Biological Psychiatry - Short Communication

Effects of experimentally induced panic attacks on neuroimmunological markers

Authors: L. de la Fontaine, M. J. Schwarz, D. Eser, N. Müller, R. Rupprecht, P. Zwanzger

Published in: Journal of Neural Transmission | Issue 6/2009

Abstract

Since little is known concerning regulation of immunological parameters in rapid changing psychiatric states like panic attacks, we measured cytokines at different time points in healthy subjects, which underwent experimental panic induction using the CCK-4 paradigm. Apart from a challenge related IL-6 increase, we could not observe any changes of neuroimmunological markers in relation to acute anxiety with regard to time and group. Herein we conducted for the first time a new approach to immunological research in panic disorder, suggesting immune changes are more related to long term disease stress.

Andreoli A, Keller SE, Rabaeus M, Zaugg L, Garrone G, Taban C (1992) Immunity, major depression, and panic disorder comorbidity. Biol Psychiatry 31:896–908PubMedCrossRef

Bradwejn J, Koszycki D (2001) Cholecystokinin and panic disorder: past and future clinical research strategies. Scand J Clin Lab Invest Suppl 234:19–27PubMed

Brambilla F, Bellodi L, Perna G (1999) Plasma levels of tumor necrosis factor-alpha in patients with panic disorder: effect of alprazolam therapy. Psychiatry Res 89:21–27PubMedCrossRef

Brambilla F, Bellodi L, Perna G, Battaglia M, Sciuto G, Diaferia G, Petraglia F, Panerai A, Sacerdote P (1992) Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology 26:12–22PubMedCrossRef

Brambilla F, Bellodi L, Perna G, Bertani A, Panerai A, Sacerdote P (1994) Plasma interleukin-1-beta plasma concentrations in panic disorder. Psychiatry Res 54:135–142PubMedCrossRef

Calandra T, Bucala R (1997) Macrophage inhibitory factor: a glucocorticoid counter-regulator within the immune system. Crit Rev Immunol 17:77–88PubMed

Erhardt A, Ising M, Unschuld PG, Kern N, Lucae S, Pütz B, Uhr M, Binder EB, Holsboer F, Keck ME (2006) Regulation of the hypothalamic-pituitary-adrenocortical system in patients with panic disorder. Neuropsychopharmacology 31:2515–2522PubMedCrossRef

Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky N, Popovic V, Bucala R, Grossman AB (2002) Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing’s disease. J Clin Endocrinol Metab 87:1834–1840PubMedCrossRef

Koh KB, Lee Y (2004) Reduced anxiety levels by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychother Psychosom 73:286–292PubMedCrossRef

Maes M (1999) Major depression and activation of the inflammatory response system. Adv Exp Med Biol 461:25–46PubMedCrossRef

Maes M, Lin A, Delmaire L, Van Gastel A, Kenis G, De Jongh R, Bosman E (1999) Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder after accidental man-made traumatic events. Biol Psychiatry 45:833–839PubMedCrossRef

Maes M, Song C, Lin A, De Jongh R, Van Gastel A, Kenis G, Bosman E, De Meester I, Benoy I, Neels H, Demedts P, Janca A, Scharpé S, Smith RS (1998) The effect of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10:313–318PubMedCrossRef

Müller N, Hofschuster E, Ackenheil M, Mempel W, Eckstein R (1993) Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog Neuropsychopharmacol Biol Psychiatry 17:713–730PubMedCrossRef

O’Brien SM, Scott LV, Dinan TG (2004) Cytokines: abnormalities in major depression and implications for pharmacological treatment. Hum Psychopharmacol Clin Exp 19:397–403CrossRef

Rapaport MH, Stein MB (1994) Serum cytokine and soluble interleukin-2 receptors in patients with panic disorder. Anxiety 1:22–25PubMed

Smith RS (1991) The macrophage theory of depression. Med Hypotheses 35:298–306PubMedCrossRef

Suarez EC, Boyle SH, Lewis JG, Hall RP, Young KH (2006) Increases in stimulated secretion of proinflammatory cytokines by blood monocytes following arousal of negative affect: the role of insulin resistance as moderator. Brain Behav Immun 20:331–338PubMedCrossRef

Vgontzas AN, Bixler EO, Lin H-M, Prolo P, Trakada G, Chrousos GP (2005) IL-6 and its circadian secretion in humans. Neuroimmunomodulation 12:131–140PubMedCrossRef

Webster JI, Tonelli L, Sternberg EM (2002) Neuroendocrine regulation of Immunity. Annu Rev Immunol 20:125–163PubMedCrossRef

Weizman R, Laor N, Wiener Z, Wolmer L, Bessler H (1999) Cytokine production in panic disorder patients. Clin Neuropharmacol 22:107–109PubMedCrossRef

Zwanzger P, Baghai TC, Schuele C, Strohle A, Padberg F, Kathmann N, Schwarz M, Möller HJ, Rupprecht R (2001) Vigabatrin decreases cholecystokinin-tetrapeptide (CCK4) induced panic in healthy volunteers. Neuropsychopharmacology 25:699–703PubMedCrossRef

Title: Effects of experimentally induced panic attacks on neuroimmunological markers
Authors: L. de la Fontaine
M. J. Schwarz
D. Eser
N. Müller
R. Rupprecht
P. Zwanzger
Publication date: 01-06-2009
Publisher: Springer Vienna
Published in: Journal of Neural Transmission / Issue 6/2009
Print ISSN: 0300-9564
Electronic ISSN: 1435-1463
DOI: https://doi.org/10.1007/s00702-008-0140-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effects of experimentally induced panic attacks on neuroimmunological markers

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2009

Decreased anxiety in mice lacking the organic cation transporter 3

The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders

Anxiolytic effects of transcranial magnetic stimulation—an alternative treatment option in anxiety disorders?

Toward and away from spiders: eye-movements in spider-fearful participants

Pharmacogenetics of anxiolytic drugs

Early cortical processing of natural and artificial emotional faces differs between lower and higher socially anxious persons